Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,174 across all filing types
Latest filing 2026-01-11 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
募集资金管理制度（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and details the management, use, supervision, and disclosure of funds raised by the company through stock issuance. It references regulatory frameworks and internal company rules for managing raised capital, including the establishment of special accounts, usage restrictions, changes in fund usage, and reporting requirements. The document is a detailed policy or procedural document related to the management of capital raised by the company, not a financial report, earnings release, or announcement. It does not contain financial statements or results but rather governance and management rules regarding fundraising capital. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices.
2026-01-11 Chinese
董事会秘书工作细则（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules' or 'Board Secretary Work Guidelines'. It details the qualifications, duties, appointment, and responsibilities of the company's board secretary. It references company law, stock exchange listing rules, and internal governance. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal rules document about the board secretary role and responsibilities. Therefore, it fits the category of Governance Information (CGR). The document length is 3690 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Hence, the classification is CGR with high confidence.
2026-01-11 Chinese
关于公司聘请H股发行及上市的审计机构的公告
Capital/Financing Update Classification · 90% confidence The document is an announcement regarding the company's decision to appoint an audit firm (Deloitte) for its H-share issuance and listing. It details the qualifications and background of the audit firm, the board's approval, and the need for shareholder approval. The document does not contain any financial statements, audit reports, or detailed financial data. It is a formal announcement about the appointment of an auditor related to a capital market transaction (H-share issuance and listing). Given the content and length (1662 characters), it is not a full audit report or annual report but an announcement related to audit services for a financing event. This fits best under Capital/Financing Update (CAP) as it relates to the company's financing activity and auditor appointment for that purpose.
2026-01-11 Chinese
独立董事提名人声明与承诺（王铮）
Board/Management Information Classification · 95% confidence The document is a detailed statement and commitment by a nominator regarding the nomination of an independent director candidate for the company's board. It includes declarations about the candidate's qualifications, compliance with regulatory requirements, and independence. This type of document is related to board or management information, specifically about changes or nominations in the company's board of directors. It is not an annual report, audit report, earnings release, or any other financial report. It is also not a proxy solicitation or voting results announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 4201 characters, which is sufficient for a detailed statement rather than a brief announcement.
2026-01-11 Chinese
年报信息披露重大差错责任追究制度（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled as a "重大差错责任追究制度" (Major Error Responsibility Accountability System) related to the disclosure of annual report information by the company. It outlines the responsibilities, accountability, and procedures for handling significant errors in the annual report disclosures. The content is regulatory and procedural in nature, focusing on internal rules and accountability mechanisms rather than presenting actual financial data or the annual report itself. The document is relatively short (2576 characters) and does not contain financial statements or substantive financial data. It is not an annual report (10-K) or an audit report (AR), but rather a governance or compliance document related to annual report disclosures. Given the focus on internal rules and governance related to disclosure responsibilities, the most appropriate classification is Governance Information (CGR).
2026-01-11 Chinese
利益冲突管理制度（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled '利益冲突管理制度' which translates to 'Conflict of Interest Management System'. It outlines policies and procedures for managing conflicts of interest among the company's directors and senior management, referencing regulatory rules such as the Shenzhen Stock Exchange GEM Listing Rules and the Hong Kong Stock Exchange Listing Rules. The content is a governance policy document detailing internal rules and procedures rather than financial data, earnings, or regulatory filings. It does not contain financial statements or results, nor is it an announcement or certification. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3070 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full annual/interim report.
2026-01-11 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.